Localized scleroderma: clinical spectrum and therapeutic update.

Area of Science:

• Rheumatology
• Dermatology
• Connective Tissue Diseases

Background:

• Scleroderma is a rare connective tissue disease with cutaneous sclerosis and potential systemic involvement.
• It presents as systemic sclerosis (cutaneous and visceral) or localized scleroderma (morphea), historically considered benign and skin-confined.
• Emerging evidence suggests localized scleroderma can impact internal organs, leading to variable morbidity.

Purpose of the Study:

• To review the key aspects and specific treatment considerations for localized scleroderma.
• To emphasize the importance of early intervention in managing localized scleroderma.
• To highlight the potential for significant morbidity associated with localized scleroderma.

Main Methods:

• Literature review focusing on localized scleroderma treatment.
• Analysis of recent studies on the systemic effects of localized scleroderma.
• Synthesis of clinical recommendations for early management.

Main Results:

• Localized scleroderma, despite its name, can involve internal organs.
• Early treatment initiation is vital to mitigate potential complications.
• Effective management strategies are essential due to the disease's variable morbidity.

Conclusions:

• Localized scleroderma requires prompt and specialized treatment.
• Understanding the potential for systemic involvement is critical for comprehensive patient care.
• This review provides insights into optimizing treatment for localized scleroderma patients.